Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans.

The pathogenic fungus Cryptococcus neoformans infects humans upon inhalation and causes the most common fungal meningoencephalitis in immunocompromised subjects worldwide. In the host, C. neoformans is found both intracellularly and extracellularly, but how these two components contribute to the development of the disease is largely unknown. Here we show that the glycosphingolipid glucosylceramide (GlcCer), which is present in C. neoformans, was essential for fungal growth in host extracellular environments, such as in alveolar spaces and in the bloodstream, which are characterized by a neutral/alkaline pH, but not in the host intracellular environment, such as in the phagolysosome of macrophages, which is characteristically acidic. Indeed, a C. neoformans mutant strain lacking GlcCer did not grow in vitro at a neutral/alkaline pH, yet it had no growth defect at an acidic pH. The mechanism by which GlcCer regulates alkali tolerance was by allowing the transition of C. neoformans through the cell cycle. This study establishes C. neoformans GlcCer as a key virulence factor of cryptococcal pathogenicity, with important implications for future development of new antifungal strategies.

[1]  M. Ohnishi,et al.  Presence of glucosylceramide in yeast and its relation to alkali tolerance of yeast , 2006, Applied Microbiology and Biotechnology.

[2]  C. Steegborn,et al.  Cryptococcus neoformans Senses CO2 through the Carbonic Anhydrase Can2 and the Adenylyl Cyclase Cac1 , 2006, Eukaryotic Cell.

[3]  M. Del Poeta,et al.  Role of Sphingolipids in Microbial Pathogenesis , 2006, Infection and Immunity.

[4]  M. Tuite,et al.  Fungal Adenylyl Cyclase Integrates CO2 Sensing with cAMP Signaling and Virulence , 2005, Current Biology.

[5]  J. Heitman,et al.  Carbonic Anhydrase and CO2 Sensing during Cryptococcus neoformans Growth, Differentiation, and Virulence , 2005, Current Biology.

[6]  W. Leuchtenberger,et al.  Biotechnological production of amino acids and derivatives: current status and prospects , 2005, Applied Microbiology and Biotechnology.

[7]  K. Hanada Sphingolipids in infectious diseases. , 2005, Japanese journal of infectious diseases.

[8]  A. Merrill,et al.  Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. , 2005, Methods.

[9]  R. Wait,et al.  A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages. , 2004, Microbes and infection.

[10]  B. Thomma,et al.  Defensins from Insects and Plants Interact with Fungal Glucosylceramides* , 2004, Journal of Biological Chemistry.

[11]  E. Heinz,et al.  Recently discovered functions of glucosylceramides in plants and fungi , 2003, Cellular and Molecular Life Sciences CMLS.

[12]  Fabrice Chrétien,et al.  Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. , 2002, The Journal of infectious diseases.

[13]  J. Shayman,et al.  Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP‐Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth , 2002, FEBS letters.

[14]  R. Wait,et al.  Characterization of glucosylceramides in Pseudallescheria boydii and their involvement in fungal differentiation. , 2002, Glycobiology.

[15]  A. Casadevall,et al.  Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Casadevall,et al.  Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Heinz,et al.  Glucosylceramide Synthases, a Gene Family Responsible for the Biosynthesis of Glucosphingolipids in Animals, Plants, and Fungi* , 2001, The Journal of Biological Chemistry.

[18]  S. Levitz Cryptococcus neoformans: intracellular or extracellular? , 2001, Trends in microbiology.

[19]  R. Pagano,et al.  Identification of Active Site Residues in Glucosylceramide Synthase , 2001, The Journal of Biological Chemistry.

[20]  A. Casadevall,et al.  Intracellular parasitism of macrophages by Cryptococcus neoformans. , 2001, Trends in microbiology.

[21]  E. Suzuki,et al.  Characterization of cerebrosides from the thermally dimorphic mycopathogen Histoplasma capsulatum: expression of 2-hydroxy fatty N-acyl (E)-Delta(3)-unsaturation correlates with the yeast-mycelium phase transition. , 2001, Glycobiology.

[22]  A. Casadevall,et al.  Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. , 2001, Genes & development.

[23]  S. Levery,et al.  Structure elucidation of sphingolipids from the mycopathogen Sporothrix schenckii: identification of novel glycosylinositol phosphorylceramides with core manalpha1-->6Ins linkage. , 2001, Biochemical and biophysical research communications.

[24]  E. Suzuki,et al.  Characterization of monoclonal antibody MEST-2 specific to glucosylceramide of fungi and plants. , 2001, Glycobiology.

[25]  W. de Souza,et al.  Human Antibodies against a Purified Glucosylceramide from Cryptococcus neoformans Inhibit Cell Budding and Fungal Growth , 2000, Infection and Immunity.

[26]  E. Heinz,et al.  Characterization of UDP-glucose:ceramide glucosyltransferases from different organisms. , 2000, Biochemical Society transactions.

[27]  A. Casadevall,et al.  Cryptococcus neoformans Is a Facultative Intracellular Pathogen in Murine Pulmonary Infection , 2000, Infection and Immunity.

[28]  S. Levery,et al.  Dimorphic expression of cerebrosides in the mycopathogen Sporothrix schenckii. , 2000, Journal of lipid research.

[29]  A. Merrill,et al.  Structure determination of soybean and wheat glucosylceramides by tandem mass spectrometry. , 2000, Journal of mass spectrometry : JMS.

[30]  E. Suzuki,et al.  Characterization of sphingolipids from mycopathogens: factors correlating with expression of 2-hydroxy fatty acyl (E)-Delta 3-unsaturation in cerebrosides of Paracoccidioides brasiliensis and Aspergillus fumigatus. , 1999, Biochemistry.

[31]  T. Harrison,et al.  Cryptococcus neoformans Resides in an Acidic Phagolysosome of Human Macrophages , 1999, Infection and Immunity.

[32]  E. Suzuki,et al.  Isolation and possible composition of glucosylceramides from Paracoccidioides brasiliensis. , 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[33]  Y. Hirabayashi,et al.  Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Casadevall,et al.  Cryptococcus neoformans survive and replicate in human microglia. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[35]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[36]  E. Suzuki,et al.  Glycolipids from Paracoccidioides brasiliensis. Isolation of a galactofuranose-containing glycolipid reactive with sera of patients with paracoccidioidomycosis. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[37]  B. Frommer,et al.  The discovery of australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity. , 1995, The Journal of antibiotics.

[38]  H. Egge,et al.  Structural determination of N-2'-hydroxyoctadecenoyl-1-O-beta-D-glucopyranosyl-9-methyl-4, 8-sphingadienine from species of Aspergillus. , 1994, Chemistry and physics of lipids.

[39]  A. J. Shaka,et al.  Iterative schemes for bilinear operators; application to spin decoupling , 1988 .

[40]  Y. Banno,et al.  Cerebroside of the dimorphic human pathogen, Candida albicans. , 1987, Chemistry and physics of lipids.

[41]  J. Perfect,et al.  Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. , 1985, The Journal of clinical investigation.

[42]  S. Klotz,et al.  The critical role of CO2 in the morphogenesis of Coccidioides immitis in cell-free subcutaneous chambers. , 1984, The Journal of infectious diseases.

[43]  J. Sanders,et al.  The suppression of Bloch-Siegert shifts and subtraction artifacts in double-resonance difference spectroscopy , 1982 .

[44]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.